Clinical Trial Update: Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML [Phase 2]

View source ↗

Summary

Phase 2 trial update for flu/Alemtuzumab/TBI followed by donor stem cell transplant in chronic myeloid leukemia in chronic phase; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2011-08-02